Markham C. Luke
Elsevier Health Sciences
e druk, 2022
9780323849692
Food and Drug Administration’s Role in Dermatology, An Issue of Dermatologic Clinics
Specificaties
Gebonden, blz.
|
Engels
Elsevier Health Sciences |
2022
ISBN13: 9780323849692
Rubricering
Onderdeel van serie
The Clinics: Internal Medicine
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
In this issue, guest editors bring their considerable expertise to this important topic.
Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Specificaties
Inhoudsopgave
The History of Dermatology and Dermatologists at the US Food and Drug Administration<br>The Food and Drug Administration’s Role in Dermatologic Drug Development<br>Postmarket Assessment for Drugs and Biologics Used in Dermatology and Cutaneous Adverse Drug Reactions<br>How Does the Food and Drug Administration Approve Topical Generic Drugs Applied to the Skin?<br>Dermatology Drugs for Children—U.S. Food and Drug Administration Perspective<br>Regulation of Medical Devices for Dermatology<br>Regulation of Cosmetics in the United States<br>Cutaneous Pharmacokinetic Approaches to Compare Bioavailability and/or Bioequivalence for Topical Drug Products<br>Measuring What Matters to Patients in Dermatology Drug Development: A Regulatory Perspective